MDPI and ACS Style
Ly, T.T.G.; Yun, J.; Ha, J.-S.; Kim, Y.-J.; Jang, W.-B.; Van Le, T.H.; Rethineswaran, V.K.; Choi, J.; Kim, J.-H.; Min, S.-H.;
et al. Inhibitory Effect of Etravirine, a Non-Nucleoside Reverse Transcriptase Inhibitor, via Anterior Gradient Protein 2 Homolog Degradation against Ovarian Cancer Metastasis. Int. J. Mol. Sci. 2022, 23, 944.
https://doi.org/10.3390/ijms23020944
AMA Style
Ly TTG, Yun J, Ha J-S, Kim Y-J, Jang W-B, Van Le TH, Rethineswaran VK, Choi J, Kim J-H, Min S-H,
et al. Inhibitory Effect of Etravirine, a Non-Nucleoside Reverse Transcriptase Inhibitor, via Anterior Gradient Protein 2 Homolog Degradation against Ovarian Cancer Metastasis. International Journal of Molecular Sciences. 2022; 23(2):944.
https://doi.org/10.3390/ijms23020944
Chicago/Turabian Style
Ly, Thanh Truong Giang, Jisoo Yun, Jong-Seong Ha, Yeon-Ju Kim, Woong-Bi Jang, Thi Hong Van Le, Vinoth Kumar Rethineswaran, Jaewoo Choi, Jae-Ho Kim, Sang-Hyun Min,
and et al. 2022. "Inhibitory Effect of Etravirine, a Non-Nucleoside Reverse Transcriptase Inhibitor, via Anterior Gradient Protein 2 Homolog Degradation against Ovarian Cancer Metastasis" International Journal of Molecular Sciences 23, no. 2: 944.
https://doi.org/10.3390/ijms23020944